Medtronic Guardian 4 Review: Accuracy, Cost, and Wear Time
The Medtronic Guardian 4 is a 7-day real-time cgm continuous glucose monitor with a 8.7% MARD accuracy rating and a GlucoseIntel score of 4.2/5.0. The Medtronic Guardian 4 is a 7-day real-time CGM designed primarily for integration with the MiniMed 780G automated insulin delivery system. FDA-cleared in 2023 for ages 7 and up, it features an 8.7% MARD, no required calibration, and a rechargeable transmitter lasting up to 1 year. Best suited for Medtronic pump users seeking a closed-loop system.
As a prescription CGM, the Medtronic Guardian 4 is FDA-cleared for diabetes management and requires a doctor's order. Insurance coverage is widely available for qualifying patients, bringing the monthly cost to $30–$50 per month. Without insurance, the out-of-pocket cost is $200–$300 per month. Medicare Part B covers the Medtronic Guardian 4 for patients who meet eligibility criteria, including documented insulin use and a valid prescription from their treating physician.
Released in 2023 by Medtronic plc (Dublin, Ireland), the Medtronic Guardian 4 uses electrochemical (glucose oxidase) technology to measure glucose in interstitial fluid. It is factory-calibrated and requires no fingerstick confirmations during use. The warmup period after sensor insertion is 120 minutes, longer than most competing devices.
Medtronic Guardian 4
by Medtronic
Key Specifications
| Product | MARD | Wear Time | Type | Rx? | With Insurance | Without Insurance | Medicare | Rating |
|---|---|---|---|---|---|---|---|---|
| Medtronic Guardian 4 | 8.7% | 7 days | Real time CGM | Yes | $30–$50 per month | $200–$300 per month | ✓ | 4.2 |
Sensor Type
Electrochemical (glucose oxidase)
Water Resistance
IP68 — waterproof up to 2.4 meters for 24 hours
Age Approval
7 years and older
Transmitter Life
1 year (rechargeable)
How Accurate Is the Medtronic Guardian 4?
The Medtronic Guardian 4 has a Mean Absolute Relative Difference (MARD) of 8.7%, which measures the average percentage error between CGM readings and simultaneous laboratory blood glucose measurements. A lower MARD indicates higher accuracy. For context, the most accurate consumer CGM in 2026 is the FreeStyle Libre 3 Plus at 7.9% MARD, while the industry range spans from 7.9% to approximately 9.2% among FDA-cleared devices.
A 8.7% MARD places the Medtronic Guardian 4 in the middle of the accuracy spectrum for current-generation CGMs. This accuracy level is suitable for glucose trend monitoring, meal response tracking, and general diabetes management. Readings may occasionally differ from a simultaneous fingerstick by 10-15 mg/dL, which is clinically acceptable for most monitoring purposes but warrants attention when making insulin correction doses.
Accuracy is highest during stable glucose periods and lowest during rapid rates of change — such as the first 60 to 90 minutes after a high-carbohydrate meal or during intense physical exercise. The physiological lag between interstitial fluid glucose (where the sensor measures) and blood glucose (what a fingerstick shows) is typically 5 to 15 minutes. Learn more about how MARD is calculated and what it means for your daily monitoring on our MARD glossary page.
What Does the Medtronic Guardian 4 Cost?
With insurance, the Medtronic Guardian 4 costs $30–$50 per month. Without insurance, the price is $200–$300 per month. Medicare Part B covers the Medtronic Guardian 4 for qualifying patients with diabetes who use insulin. Medicare copays typically range from $0 to $50 per month depending on the specific plan and supplemental coverage.
The annual cost of the Medtronic Guardian 4 depends on sensor replacement frequency. With a 7-day sensor life, users need approximately 53 sensors per year. The shorter sensor life means more frequent replacements, which increases annual costs compared to 14-day and 15-day sensors.
For a complete breakdown of CGM costs across all devices, including manufacturer discount programs and patient assistance options, see our comprehensive CGM cost guide.
Sensor Wear Time: 7 Days
The Medtronic Guardian 4 sensor lasts 7 days before requiring replacement. The 7-day wear time means approximately 53 sensor changes per year. This is shorter than the 14 to 15-day sensors from Abbott and the 15-day Dexcom G7 variant, resulting in more frequent insertions and potentially higher annual sensor costs.
After inserting a new sensor, the Medtronic Guardian 4 requires 120 minutes to stabilize before glucose readings become available. During this warmup period, no glucose data is transmitted.
App and Data Sharing
The Medtronic Guardian 4 pairs with a dedicated smartphone app that displays real-time glucose values, trend arrows, and historical data. The device supports data sharing with caregivers, family members, and healthcare providers, allowing remote monitoring of glucose levels and alerts. Customizable high and low glucose alerts notify users when blood sugar moves outside their target range, and trend-based notifications provide advance warning of rising or falling glucose.
The Medtronic Guardian 4 is compatible with Medtronic MiniMed 780G insulin pump for automated insulin delivery (closed-loop) systems. When paired with a compatible pump, the CGM continuously feeds glucose data to the pump's algorithm, which automatically adjusts basal insulin delivery to keep glucose in the target range. This integration reduces the manual burden of insulin management and has been shown in clinical trials to increase time in range by 10 to 15 percentage points compared to manual pump therapy.
Pros and Cons
Pros
- Tight integration with MiniMed 780G for automated insulin delivery
- No fingerstick calibration required (non-adjunctive labeling)
- Rechargeable transmitter lasts up to 1 year — reduces ongoing cost
- Smart Guard predictive alerts help prevent highs and lows
- Real-time glucose readings every 5 minutes
- Medicare Part B coverage when used with MiniMed 780G system
Cons
- 7-day sensor life — shortest of any current CGM (competitors offer 10–15 days)
- 2-hour warmup period — the longest in the CGM market
- Only compatible with Medtronic pumps — no Omnipod or Tandem integration
- Higher sensor replacement frequency increases annual cost
- Age approval starts at 7 — competitors approve from age 2–4
- Separate transmitter must be charged and maintained
- Standalone use (without pump) provides less value than competitors
Who Should Use the Medtronic Guardian 4?
The Medtronic Guardian 4 is best suited for patients with type 1 diabetes, insulin-dependent type 2 diabetes, or any condition requiring tight glucose management with automated insulin delivery. Its integration with Medtronic MiniMed 780G makes it the CGM of choice for closed-loop pump users. Patients who prioritize fast sensor warmup (120 minutes) and real-time predictive alerts will find the Medtronic Guardian 4 aligns with their clinical needs.
How Does the Medtronic Guardian 4 Compare?
See how the Medtronic Guardian 4 stacks up against competing continuous glucose monitors in our head-to-head comparison guides. Each comparison evaluates accuracy, wear time, cost, features, and which device is better for specific use cases.
Medtronic Guardian 4
by Medtronic